Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein
KEYWORDS: people, vte, prophylaxis, risk, vte prophylaxis, surgery, lmwh, use, risk vte, pharmacological, consider, bleeding, undergoing, people undergoing, person

2018, the use of LMWH in young people under 18 in recommendations 1.12.7, 1.12.8 and 1.12.9 was off label. See NICE's information on prescribing medicines. 1.12.5 Consider mechanical VTE prophylaxis for people undergoing cranial surgery. [2018] 1.12.6 If using mechanical VTE prophylaxis for people undergoing cranial surgery, start it on admission. Choose either: • anti-embolism stockings or • intermittent pneumatic compression. Continue for 30 days or until the person is mobile or discharged, whichever is sooner. [2018] 1.12.7 Consider adding pre-operative pharmacological VTE prophylaxis with LMWH. Give the last dose no less than 24 hours before surgery for people undergoing cranial surgery whose risk of VTE outweighs their risk of bleeding. [2018] 1.12.8 Consider adding pharmacological VTE prophylaxis with LMWH, starting 24 to 48 hours after surgery for people undergoing cranial surgery whose risk of VTE outweighs their risk of bleeding. Continue for a minimum of 7 days. [2018] 1.12.9 If needed, start LMWH earlier than 24 hours after the operation for people undergoing cranial surgery. Base the decision on multidisciplinary or senior opinion, or a locally agreed protocol. [2018] 1.12.10 Do not offer pharmacological VTE prophylaxis to people with ruptured cranial vascular malformations (for example, brain aneurysms) or people
